Basic studies on gene therapy of human malignant melanoma by use of the human interferon β gene entrapped in cationic multilamellar liposomes.: 1.: Morphology and growth rate of six melanoma cell lines used in transfection experiments with the human interferon β gene

被引:18
作者
Benga, G
机构
[1] Univ Med & Pharm Cluj Iuliu Hatieganu, Dept Cell & Mol Biol, Cluj Napoca 3400, Romania
[2] Inst Appl Biochem, Gifu, Japan
关键词
malignant melanoma; cell lines; gene therapy;
D O I
10.1111/j.1582-4934.2001.tb00175.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Six cell lines of human malignant melanoma: A375, A375.2, 6361, HMV-1, MM8.1 and WM115 were seeded at densities of 1x10(4) cells/ml, 2x10(4) cells/ml or 3x10(4) cells/ml of RPMI medium supplemented with 10% fetal calf serum and antibiotics in a humidified atmosfere of 5% CO2 at 37degreesC. A375 cells were also grown in Dulbecco's minimum Eagle's medium (DMEM medium). The morphology was studied by phase contrast light microscopy. At 4 days after seeding the colonies of A375 cells and HMV-1 cells were oval-shaped, the cells were polyhedrical and were making contact with each other regularly. The remaining cells were scattered, more elongated, and made contact randomly. 6361 cells and MM8.1 cells tended to form superposed layers before 100% confluency was achieved. There were great differences in the growth rate and doubling time of melanoma cells. The doubling time in day 1 was short (around 6-12 h) in the case of A375, 6361 and HMV-1 cells, longer (around 18h) in the case of MM8.1 cells and very long (ranging between 26 and 89 h) for A375.2 and WM115 cells. There were also differences in the doubling time of cells as a function of the cell density at seeding. On the other hand, except for MM8.1 cells, there were differences between the doubling time in day 2 compared to day 1.
引用
收藏
页码:402 / 408
页数:7
相关论文
共 23 条
[11]  
Nagatani T, 1995, ACTA DERM-VENEREOL, V75, P494
[12]   Effect of natural interferon-β on the growth of melanoma cell lines [J].
Nagatani, T ;
Okazawa, H ;
Kambara, T ;
Satoh, K ;
Nishiyama, T ;
Tokura, H ;
Yamada, R ;
Nakajima, H .
MELANOMA RESEARCH, 1998, 8 (04) :295-299
[13]  
Nemunaitis J, 1998, CANCER GENE THER, V5, P292
[14]   Ex vivo delivery of suicide genes into melanoma cells using epidermal growth factor receptor-specific Fab immunogene [J].
Ohtake, Y ;
Chen, JB ;
Gamou, S ;
Takayanagi, A ;
Mashima, Y ;
Oguchi, Y ;
Shimizu, N .
JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (04) :460-468
[15]  
Shimizu M, 1998, BIOCHEM MOL BIOL INT, V44, P1235
[16]  
SPARANO JA, 1993, MELANOMA, V1, P189
[17]  
Tomoda K, 1998, ANTICANCER RES, V18, P1367
[18]   EFFICIENT GENE-TRANSFER WITH LESS CYTOTOXICITY BY MEANS OF CATIONIC MULTILAMELLAR LIPOSOMES [J].
YAGI, K ;
NODA, H ;
KURONO, M ;
OHISHI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 196 (03) :1042-1048
[19]   Basic study on gene therapy of human malignant glioma by use of the cationic multilamellar liposome-entrapped human interferon β gene [J].
Yagi, K ;
Ohishi, N ;
Hamada, A ;
Shamoto, M ;
Ohbayashi, M ;
Ishida, N ;
Nagata, A ;
Kanazawa, S ;
Nishikimi, M .
HUMAN GENE THERAPY, 1999, 10 (12) :1975-1982
[20]  
YAGI K, 1994, BIOCHEM MOL BIOL INT, V32, P167